Back

Onconetix advances $2.5 million to Realbotix ahead of planned acquisition

Verifying
  • Onconetix provided Realbotix with a strategic bridge financing facility.
  • $2.5 million was advanced initially under a facility capped at $5 million.
  • The facility will be cancelled at acquisition closing, subject to required approvals.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.